Skip to main content
AMINOLOGICS CO.,LTD. logo

AMINOLOGICS CO.,LTD. — Investor Relations & Filings

Ticker · 074430 ISIN · KR7074430000 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2021-03-08 AGM Information
Country KR South Korea
Listing KO 074430

About AMINOLOGICS CO.,LTD.

https://aminologics.co.kr/eng/main/

AMINOLOGICS CO.,LTD. is a specialty manufacturer of amino acids and their derivatives. The company's core competency is its proprietary chiral resolution platform technology, ARCA (Alanine Racemase Chiral). This innovative enzymatic process enables the cost-effective production of a wide range of high-purity chiral amino acids. These products serve as essential building blocks and Active Pharmaceutical Ingredients (APIs) for various sectors, including the pharmaceutical, fine chemical, agrochemical, and life science industries. The technology allows for the development of new products and treatments by providing materials with high optical purity at a reduced cost.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for AminoLogics Co., Ltd. It contains the meeting agenda, voting procedures, electronic voting instructions, and management reference materials (business overview, financial information). This type of document is standard for providing shareholders with the necessary information to vote at an upcoming Annual General Meeting. In the context of the provided categories, this is a Proxy Solicitation & Information Statement (PSI) as it provides the information and materials required for shareholders to exercise their voting rights.
2021-03-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by AminoLogics. It outlines the date, location, and agenda items (financial statement approval, director/auditor appointments, etc.) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation material used to inform shareholders of meeting details and request their participation or proxy votes, fitting the definition of Proxy Solicitation & Information Statement.
2021-03-02 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (AminoLogics) regarding a significant change in financial structure (30% or more change in revenue or profit). This is a standard disclosure requirement in the Korean market (DART system) for material financial events. Since it provides key financial highlights and profit/loss structure changes rather than a full annual report or a simple announcement of a report's availability, it falls under the 'Earnings Release' category as it serves as the initial announcement of financial performance. FY 2020
2021-02-01 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal regulatory notice of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-16 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Aminologics (아미노로직스) covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-16 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Aminologics Co., Ltd.' covering the period from January 1, 2020, to June 30, 2020. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.